Literature DB >> 9056128

Differential features between bipolar I and bipolar II disorder.

E Vieta1, C Gastó, A Otero, E Nieto, J Vallejo.   

Abstract

Although bipolar II disorder is generally viewed as a mild form of classic manic-depressive illness, recent investigations suggest that it could be a valid diagnostic category different from bipolar I in genetic, biological, clinical, and pharmacological aspects. Twenty-two patients fulfilling Research Diagnostic Criteria for the diagnosis of bipolar II disorder and 38 bipolar I patients were evaluated with the Schedule for Affective Disorders and Schizophrenia by two independent interviewers and compared. Bipolar II patients had significantly more previous episodes (P = .001), including both depressive (P = .003) and hypomanic (P = .006) switches, but had been hospitalized (P = .001) and presented psychotic symptoms (P < .001) less frequently. These results suggest that bipolar II disorder is less severe than bipolar I with regard to symptom intensity, but is more severe with respect to episode frequency.

Entities:  

Mesh:

Year:  1997        PMID: 9056128     DOI: 10.1016/s0010-440x(97)90088-2

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  31 in total

1.  Bipolar II Disorder: Frequent, Valid, and Reliable.

Authors:  Eduard Vieta
Journal:  Can J Psychiatry       Date:  2019-08       Impact factor: 4.356

2.  Socio-demographic and clinical characterization of patients with Bipolar Disorder I vs II: a Nationwide Italian Study.

Authors:  A Carlo Altamura; Massimiliano Buoli; Bruno Cesana; Bernardo Dell'Osso; Gianluigi Tacchini; Umberto Albert; Andrea Fagiolini; Andrea de Bartolomeis; Giuseppe Maina; Emilio Sacchetti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-01       Impact factor: 5.270

3.  Interaction of DRD2TaqI, COMT, and ALDH2 genes associated with bipolar II disorder comorbid with anxiety disorders in Han Chinese in Taiwan.

Authors:  Ming-Chuan Hu; Sheng-Yu Lee; Tzu-Yun Wang; Yun-Hsuan Chang; Shiou-Lan Chen; Shih-Heng Chen; Chun-Hsien Chu; Chen-Lin Wang; I Hui Lee; Po See Chen; Yen Kuang Yang; Ru-Band Lu
Journal:  Metab Brain Dis       Date:  2014-11-29       Impact factor: 3.584

4.  A longitudinal study of the association between the GNB3 C825T polymorphism and metabolic disturbance in bipolar II patients treated with valproate.

Authors:  P S Chen; H H Chang; C-C Huang; C C Lee; S-Y Lee; S-L Chen; S-Y Huang; Y K Yang; R-B Lu
Journal:  Pharmacogenomics J       Date:  2016-02-09       Impact factor: 3.550

5.  A qualitative investigation of hypomania and depression in bipolar II disorder.

Authors:  Kathryn Fletcher; Gordon Parker; Vijaya Manicavasagar
Journal:  Psychiatr Q       Date:  2013-12

6.  Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.

Authors:  Sheng-Yu Lee; Shiou-Lan Chen; Yun-Hsuan Chang; Po See Chen; San-Yuan Huang; Nian-Sheng Tzeng; Yu-Shan Wang; Liang-Jen Wang; I Hui Lee; Tzung Lieh Yeh; Yen Kuang Yang; Ru-Band Lu; Jau-Shyong Hong
Journal:  J Psychiatr Res       Date:  2013-07-18       Impact factor: 4.791

Review 7.  Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V.

Authors:  Mary L Phillips; Eduard Vieta
Journal:  Schizophr Bull       Date:  2007-06-11       Impact factor: 9.306

8.  Depressive residual symptoms are associated with illness course characteristics in a sample of outpatients with bipolar disorder.

Authors:  Gianluca Serafini; Gustavo H Vazquez; Xenia Gonda; Maurizio Pompili; Zoltan Rihmer; Mario Amore
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-02-07       Impact factor: 5.270

Review 9.  Burden of bipolar depression: impact of disorder and medications on quality of life.

Authors:  Erin E Michalak; Greg Murray; Allan H Young; Raymond W Lam
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 10.  The Prevalence and Diagnostic Validity of Short-Duration Hypomanic Episodes and Major Depressive Episodes.

Authors:  Shefali Miller; Ellen B Dennehy; Trisha Suppes
Journal:  Curr Psychiatry Rep       Date:  2016-03       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.